HZ
EW icon

Hixon Zuercher’s Edwards Lifesciences EW Stock Holding History

Hixon Zuercher’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.76M Sell
30,496
-421
-1% -$35.3K 0.81% 41
2026
Q1 		$2.48M Sell
30,917
-399
-1% -$32.9K 0.77% 47
2025
Q4 		$2.67M Buy
31,316
+988
+3% +$81.1K 0.81% 42
2025
Q3 		$2.36M Sell
30,328
-403
-1% -$31.5K 0.72% 50
2025
Q2 		$2.4M Buy
30,731
+226
+0.7% +$16.9K 0.78% 48
2025
Q1 		$2.21M Buy
30,505
+5,421
+22% +$388K 0.78% 49
2024
Q4 		$1.86M Sell
25,084
-2,533
-9% -$177K 0.71% 50
2024
Q3 		$1.82M Buy
27,617
+312
+1% +$22.7K 0.71% 52
2024
Q2 		$2.52M Buy
27,305
+676
+3% +$59.9K 1.06% 35
2024
Q1 		$2.54M Buy
26,629
+1,086
+4% +$91.2K 1.08% 37
2023
Q4 		$1.95M Buy
25,543
+559
+2% +$38.9K 0.9% 41
2023
Q3 		$1.73M Buy
24,984
+1,747
+8% +$140K 0.91% 40
2023
Q2 		$2.19M Buy
23,237
+275
+1% +$23.9K 1.1% 34
2023
Q1 		$1.9M Sell
22,962
-10,241
-31% -$805K 1.13% 32
2022
Q4 		$2.48M Buy
33,203
+1,085
+3% +$83.6K 1.53% 28
2022
Q3 		$2.65M Buy
32,118
+1,246
+4% +$120K 1.69% 24
2022
Q2 		$2.94M Buy
30,872
+466
+2% +$48.2K 1.9% 23
2022
Q1 		$3.58M Buy
30,406
+720
+2% +$80.8K 1.92% 21
2021
Q4 		$3.85M Buy
29,686
+654
+2% +$76.3K 1.93% 23
2021
Q3 		$3.29M Buy
29,032
+346
+1% +$39.5K 1.92% 25
2021
Q2 		$2.97M Buy
28,686
+682
+2% +$64.3K 1.79% 29
2021
Q1 		$2.34M Buy
28,004
+1,847
+7% +$156K 1.55% 27
2020
Q4 		$2.39M Buy
26,157
+422
+2% +$35K 1.66% 24
2020
Q3 		$2.05M Buy
25,735
+180
+0.7% +$14K 1.58% 25
2020
Q2 		$1.77M Buy
25,555
+2,860
+13% +$203K 1.52% 27
2020
Q1 		$1.43M Sell
22,695
-15,384
-40% -$1.11M 2.06% 22
2019
Q4 		$2.96M Buy
+38,079
New +$2.97M 2.82% 15

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Hixon Zuercher's EW Position: Q2 2026 in Review

Hixon Zuercher reduced its Edwards Lifesciences (EW) stake by 1.4% in Q2 2026, selling an estimated $35.3K and leaving 30,496 shares worth $2.76M. The position accounts for 0.81% of the portfolio, ranked #41.

Hixon Zuercher first reported a position in EW in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.85M in Q4 2021. 372 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Hixon Zuercher held 30,496 shares of Edwards Lifesciences worth $2.76M as of Q2 2026.
  • Hixon Zuercher sold 421 Edwards Lifesciences shares in Q2 2026, an estimated $35.3K.
  • Edwards Lifesciences made up 0.81% of Hixon Zuercher's portfolio in Q2 2026, its #41 holding.
  • Hixon Zuercher first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 27 quarters since.
  • Hixon Zuercher's Edwards Lifesciences position peaked at $3.85M in Q4 2021.
  • 372 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Hixon Zuercher's 13F filing for Q2 2026, filed 20 Jul 2026.